2020 has been a year unlike any other because of the coronavirus to say the least. The coronavirus (COVID-19) has played and continues to play a huge part in our lives whether we like it or not. People all around the world are wondering, “when it is going to end?” When can we get back to some sense or normalcy? Unfortunately, that is a difficult question which has no real, clear answer. However, finding a vaccine or an effective treatment has been been said to be one of the most important factors moving forward. Here’s how you can be part of the solution.
What is the COVID-19 treatment in development?
The investigational medicine that is currently being examined for treatment and/or prevention of COVID-19 in this specific study is known as REGN-COV2. The study is sponsored by Regeneron Pharmaceuticals, Inc. Trials with this medicine began in mid-June 2020.
How do I qualify for the study?
In order to qualify for this study, you must meet one of two criteria:
- Be at least 18 years of age AND diagnosed with/suspected to have Coronavirus
- Be at least 18 years of age AND have a household member recently diagnosed with or suspected to have Coronavirus within the past 3 days
Please note that simply meeting these requirements does not automatically mean you will be chosen for the study. You will also need to complete an online questionnaire. Additionally, you will have a brief phone conversation with a study doctor to make sure you meet all criteria and understand the benefits and risks of participation.
How much will I get paid?
Adults who have a confirmed infection are eligible to receive reimbursement of up to $3,650 related to study participation. Adults who live with someone who has a confirmed infection are eligible to receive reimbursement of up to $4,875 related to study participation.
How do I find out more information and sign up?
You can navigate directly to the ClinLife COVID-19 Research Study page to get started.
How can I find other clinical trials?
Other clinical trials in which you may be interested in can be found on the ClinicalTrials.gov study listing page. You can learn about currently active research through the National Institute of Health‘s COVID-19 homepage.